Abstract 239P
Background
Oral cancer surgery includes radical resections of the mandible and tongue, affecting the functional swallowing outcomes. However, risk factors and swallowing outcomes are not the same for all subsites of oral cancer. The present study aimed to assess the difference in patient-reported swallowing function and quality of life after primary surgical resection in tongue vs bucco- alveolar complex (BAC) malignancies.
Methods
Study included oral cancer patients requiring mandibulectomy for BAC subsite and at least hemi-glossectomy for tongue, all reconstructed with pedicle flaps at our institute from Dec 2019 to Dec 2021. The Sydney Swallow Questionnaire (SSQ) and Functional oral intake scale (FOIS) were used to assess swallowing outcomes after six months DFS. WHO BREF questionnaire was used to assess health-related quality of life.
Results
The final analysis included 66 patients. The median age was 48 yrs and majority are males (92.4%). BAC constituted 63.6%, and tongue lesions were 36.4%. Tumours with cT3 and T4 are 59% of BAC and 46% of tongue lesions. In BAC, 85% underwent segmental mandibulectomy, and 87% of tongue lesions were treated with hemiglossectomy. 85.7% of BAC and 92% of tongue lesions received adjuvant radiation. Trismus and xerostomia were present in 71.4%, 85% in BAC and 50%, 75% in tongue lesions, respectively. The mean SSQ score was (282.6, SD= 95), (222.5, SD=96) BAC and tongue, respectively. Advanced T stage (p=0.07), Multimodality treatment (p=0.01), lymphedema (p=0.03), Trismus (p=0.01), Dysgeusia (p=0.01), xerostomia (p=0.01) in BAC lesions. Advanced T stage (p=0.007), Multimodality treatment (p=0.04), lymphedema (p=0.03), Dysgeusia (p=0.01) in tongue lesions are associated with poor outcomes. Almost 88% of BAC lesions required special food preparation for swallowing (FOIS 5). However, only 16.7% of tongue lesions required special preparation. There is a trend toward better health-related quality of life (HRQOL) in tongue lesions.
Conclusions
There is a difference in swallowing results between tongue and BAC cancers. Tongue lesions had more reasonable swallowing outcomes. However, overall, HRQOL is comparable between both subsites.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
186P - Degradation of BRCA2 expression by hyperthermia sensitizes HRD-negative (BRCA2 wild-type) ovarian cancer cells to niraparib
Presenter: Junyang Li
Session: Poster viewing 03
187P - BUB1 (2530C>T) polymorphism and expression affects chemotherapy response and predicts poor prognosis in advanced epithelial ovarian cancer
Presenter: Sinjini Sarkar
Session: Poster viewing 03
188P - Spatial transcriptomic analysis of tumor tissue in ovarian cancer patients treated with neoadjuvant chemotherapy
Presenter: Irina Larionova
Session: Poster viewing 03
189P - LncRNA NKILA as a negative regulator of NFkB in ascites in ovarian cancer
Presenter: Dinara Dolgova
Session: Poster viewing 03
190P - Real-world applications of poly (ADP-ribose) polymerase inhibitors for ovarian cancer: A single-center study in China
Presenter: dengfeng wang
Session: Poster viewing 03
191P - Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer
Presenter: N Thejeswar
Session: Poster viewing 03
192P - Human epididymis protein 4 as a predictor of response to neoadjuvant chemotherapy in epithelial ovarian cancer
Presenter: Sarada Planjery
Session: Poster viewing 03
193P - Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice: Experience of re-challenge mode of olaparib usage
Presenter: Alexander Sultanbaev
Session: Poster viewing 03
194P - A study of the treatment response of concomitant external beam radiotherapy (EBRT) and intracavitary brachytherapy in the management of locally advanced carcinoma of uterine cervix
Presenter: Asish Chowdhury
Session: Poster viewing 03
195P - Awareness of human papillomavirus (HPV) infection, cervical cancer (CC), and vaccine among females in Sultanate of Oman
Presenter: Abdulrahman Al-Mirza
Session: Poster viewing 03